The patent exclusivity for edarbi (azilsartan medoxomil) has largely expired, allowing for generic versions to enter the market [1].
When does edarbi patent expire?
The primary patents protecting edarbi have expired, with some key patents expiring around late 2023 or early 2024. This timing opened the door for generic manufacturers to begin producing and selling their versions of the drug [2][1].
Can I get generic edarbi now?
Yes, generic versions of edarbi are available. Following the expiration of patent protections, pharmaceutical companies have launched generic equivalents of edarbi, which are typically offered at a lower cost [1].
How does generic edarbi work?
Generic edarbi contains the same active ingredient, azilsartan medoxomil, as the brand-name drug. It works in the same way to treat high blood pressure by relaxing blood vessels, which lowers blood pressure [3]. Regulatory agencies like the U.S. Food and Drug Administration (FDA) require generic drugs to be bioequivalent to their brand-name counterparts, meaning they have the same dosage form, safety, strength, route of administration, and intended use [4].
Who makes generic edarbi?
Multiple pharmaceutical companies are authorized to produce and market generic versions of edarbi. These include companies specializing in generic drug manufacturing [1].
What is edarbi used for?
Edarbi is a medication prescribed to treat high blood pressure (hypertension) in adults. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs) [3].
What is the difference between brand-name and generic edarbi?
The primary difference between brand-name edarbi and its generic versions is the inactive ingredients, which do not affect the drug's performance. Generic drugs are approved to be therapeutically equivalent to their brand-name counterparts, meaning they are expected to have the same clinical effect and safety profile [4]. The cost is usually a significant difference, with generics being substantially less expensive [1].
What are the side effects of edarbi?
Common side effects associated with edarbi and its generics can include dizziness, fatigue, and upper respiratory tract infections. More serious, though less common, side effects may include kidney problems, low blood pressure, or allergic reactions [5]. Patients should consult their healthcare provider for a complete list of potential side effects and to discuss any concerns.
Sources:
[1] DrugPatentWatch.com
[2] Information regarding patent expirations and generic drug availability can be found at DrugPatentWatch.com.
[3] Azilsartan Medoxomil. (n.d.). MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a611007.html
[4] Generic Drugs: Q&A. (n.d.). U.S. Food & Drug Administration. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-qa
[5] Edarbi. (n.d.). Drugs.com. Retrieved from https://www.drugs.com/edarbi.html